2024/09/18 18:28:04 | |
---|---|
Price | |
14.715 EUR | |
Difference | 1.48% (0.22) |
ISIN | US0042251084 |
Symbol | ACAD |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,425 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 14.705 EUR (4,000) |
Ask (Ask size) | 14.78 EUR (4,000) |
Open | 14.53 EUR |
High | 14.745 EUR |
Low | 14.53 EUR |
Close (prev. day) | 14.50 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/18 18:28:04 | |
---|---|
Price | |
14.715 EUR | |
Difference | 1.48% (0.22) |
ISIN | US0042251084 |
Symbol | ACAD |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 2,425 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 14.705 EUR (4,000) |
Ask (Ask size) | 14.78 EUR (4,000) |
Open | 14.53 EUR |
High | 14.745 EUR |
Low | 14.53 EUR |
Close (prev. day) | 14.50 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 3 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -15.70% | -38.03% | +6.54% |
Perf (abs.) | -2.70 | -8.90 | +0.89 |
Beta | - | - | - |
Volatility | 46.03 | 56.77 | 61.32 |
Ø price 5 days | Ø volume 5 days (pcs.) | 14.504 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 14.306 EUR (0) |
Ø price 100 days | Ø volume 100 days (pcs.) | 14.857 EUR (4) |
Ø price 250 days | Ø volume 250 days (pcs.) | 18.838 EUR (8) |
YTD High | date | 28.800 EUR (2024/01/02) |
YTD Low | date | 13.330 EUR (2024/05/30) |
52 Weeks High | date | 28.800 EUR (2024/01/02) |
52 Weeks Low | date | 13.330 EUR (2024/05/30) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/09/17 | 22:02 | 14.645 EUR | 0.00 | 1 |
Stuttgart | 2024/09/18 | 18:28 | 14.715 EUR | 0.00 | 3 |
Nasdaq | 2024/09/18 | 19:31 | 16.39 USD | 4.43 | 6,387 |
Munich | 2024/09/18 | 08:03 | 14.595 EUR | 0.00 | 1 |
London Stock Exchange | 2024/09/17 | 15:33 | 16.29 USD | 0.00 | 2 |
Frankfurt | 2024/09/18 | 08:04 | 14.52 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/18 | 19:31 | 14.69 EUR | 0.00 | 5 |
Berlin | 2024/09/18 | 08:08 | 14.525 EUR | 0.00 | 1 |
ACADIA PHARMACEUTICALS INC. |
- - |
Sorrento Valley Blvd. 3911 92121 San Diego, CA |
Telefon: +1 (858) 558-2871 |
Fax: +1 (858) 558-2872 |
E-mail: info@acadia-pharm.com |
- |
Stephen Biggar | Chairman of Board of Directors |
Adora Ndu | Member of Board of Directors |
Edmund Harrigan | Member of Board of Directors |
Elizabeth Garofalo | Member of Board of Directors |
Daniel Soland | Member of Board of Directors |
James Daly | Member of Board of Directors |
Julian Baker | Member of Board of Directors |
Laura Brege | Member of Board of Directors |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer